ASHP Oncology Review Course to be Offered in Spring 2001
The American Society of Health-System Pharmacists (ASHP) will continue to provide top-notch live and online reviews for pharmacists hoping to become certified in oncology pharmacy by the Board of Pharmaceutical Specialties, thanks to a $165,000 educational grant from Aventis Pharmaceuticals. The review course will help pharmacists refresh their knowledge of concepts in oncology pharmacy in preparation for the 2001 exam.
The live version of review course, which will be held in Denver, March 31- April 1, 2001, provides attendees with a concentrated update on the various disease states and therapies, regulatory issues, pharmacology, and statistics relating to oncology pharmacy. The two-day class is composed of lectures and small-group sessions to help participants recognize where their own knowledge gaps exist and identify resources to build these skills. Attendees can individualize their course work by choosing from eight breakout sessions that deal with knowledge areas tested during the examination and will 16 hours of continuing education credit after eting the course.
The Web version of the course, offering the same extensive learning tools, allows practitioners to prepare for the exam on their own time through the Web-based program. Participants will hear an audio presentation and view accompanying slides for up to 19 course modules and will be available in July 2001.
"Such programs are key to helping pharmacists take on greater patient care roles," said ASHP President Mick L. Hunt, M.S., FASHP. "I am happy to see that we are making this important tool available both through a live course and the Web version giving virtually every interested practitioner access to the preparatory course and materials."
The course, which received kudos from former participants, is funded through an educational grant from Aventis Pharmaceuticals and was developed with the assistance of ASHP's Section of Clinical Specialists. Course material will be updated to include information on new drug agents and treatment options. "We believe that pharmacists have an important role to play in helping cancer patients manage their complex drug therapies," said Marty Duvall, Vice President of Marketing for Aventis Pharmaceuticals. "Aventis is committed to helping them strengthen their knowledge base in order to receive their oncology certification."
Enrollment is limited to 150 participants. Registration materials are available via ASHP's Web site, www.ashp.org, and by calling ASHP Customer Service at (301) 657-4383. The fee for the session is $200 for ASHP members and $260 for nonmembers before the February 15, 2001 registration deadline.
ASHP is the 30,000-member national professional association that represents pharmacists who practice in hospitals, health maintenance organizations, long-term care facilities, home care, and other components of health care systems. ASHP believes that the mission of pharmacists is to help people make the best use of medications. Assisting pharmacists in fulfilling this mission is ASHP's primary objective. The Society has extensive publishing and educational programs designed to help members improve their delivery of pharmaceutical care, and it is the national accrediting organization for pharmacy residency and pharmacy technician training programs.